Rimactane and liver disorder Patient Reports February 12, 2012

Rimactane Side Effects Report #5003895-6
Rimactane side effect was reported by a Health Professional from FRANCE on May 02, 2006. Female patient, 62 years of age, was diagnosed with sepsis  and was treated with Rimactane. After drug was administered, patient experienced the following side effects: cholestasis, condition aggravated, haemolytic anaemia, inflammation, liver disorder. Rimactane dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PRIMAXIN, VITAMIN B1, INEXIUM, SPECIAFOLDINE, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.

Rimactane Side Effects Report #4692231-0
Rimactane side effect was reported by a Consumer or non-health professional from on June 01, 2005. Male patient, 47 years of age, was diagnosed with pleurisy and was treated with Rimactane. After drug was administered, patient experienced the following side effects: gastric ulcer perforation, hepatocellular damage, liver disorder, multi-organ failure, oesophageal perforation, pneumomediastinum. Rimactane dosage: unknown. During the same period patient was treated with ETHAMBUTOL, ISONIAZID, PYRAMIDE. Patient was hospitalized. Patient died on 09/08/2004.

Rimactane Side Effects Report #4621018-X
Rimactane side effect was reported by a Physician from on Mar 16, 2005. Male patient, 69 years of age, was diagnosed with mycobacteria blood test positive and was treated with Rimactane. After drug was administered, patient experienced the following side effects: liver disorder, stevens-johnson syndrome. Rimactane dosage: unknown. During the same period patient was treated with ISONIAZID, ESANBUTOL. Patient recovered.

Rimactane Side Effects Report #4629343-3
Rimactane side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 69 years of age, was diagnosed with mycobacteria blood test positive and was treated with Rimactane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, inflammation, liver disorder, lymphocyte stimulation test positive, somnolence, stevens-johnson syndrome. Rimactane dosage: unknown. During the same period patient was treated with ISONIAZID, PYRAZINAMIDE. Patient was hospitalized. Patient recovered.